CVS Health
CVS
2,367 hedge funds and large institutions have $104B invested in CVS Health in 2022 Q1 according to their latest regulatory filings, with 173 funds opening new positions, 885 increasing their positions, 1,069 reducing their positions, and 121 closing their positions.
43% more first-time investments, than exits
New positions opened: 173 | Existing positions closed: 121
17% more call options, than puts
Call options by funds: $1.88B | Put options by funds: $1.6B
1% more funds holding
Funds holding: 2,344 → 2,367 (+23)
0.38% less ownership
Funds ownership: 78.88% → 78.5% (-0.38%)
15% less capital inflows, than outflows
Capital inflows: $5.81B | Capital outflows: $6.87B
17% less repeat investments, than reductions
Existing positions increased: 885 | Existing positions reduced: 1,069
20% less funds holding in top 10
Funds holding in top 10: 145 → 116 (-29)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$896M |
| 2 |
JP Morgan Chase
New York
|
+$490M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$276M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$272M |
| 5 |
State Street
Boston,
Massachusetts
|
+$257M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$1.19B |
| 2 |
Franklin Resources
San Mateo,
California
|
-$493M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$380M |
| 4 |
Harris Associates
Chicago,
Illinois
|
-$310M |
| 5 |
Millennium Management
New York
|
-$225M |
CVS Hedge Fund Activity: Q1 2022 in Review
2,367 of the 6,365 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2022, worth a combined $104B — down 2.8% from $107B a quarter earlier.
Buyers outnumbered sellers: 173 funds opened new CVS positions and 121 closed out — a net gain of 52 holders — while 885 added to existing stakes and 1,069 trimmed.
The largest buyer was Capital World Investors, adding an estimated $896M. The largest seller was DZ Bank, cutting an estimated $1.19B.
- 2,367 institutional investors held CVS Health (CVS) as of Q1 2022, up from 2,344 in Q4 2021.
- Funds reported $104B of CVS Health stock for Q1 2022, down 2.8% quarter-over-quarter.
- 173 funds opened new CVS Health positions in Q1 2022 and 121 closed out, a net change of +52 holders.
- The largest CVS Health buyer in Q1 2022 was Capital World Investors, an estimated $896M added.
- The largest CVS Health seller in Q1 2022 was DZ Bank, an estimated $1.19B sold.
Based on aggregated 13F filings for Q1 2022.